Teva Pharmaceutical Industries Ltd. announced the Food and Drug Administration approval and the launch of the generic equivalent to Diovan (Valsartan) Tablets in the United States. Diovan (Valsartan) Tablets, marketed by Novartis Pharmaceuticals, had annual sales of approximately $1.8 billion in the United States.